PPT-Supplementary Figure 1 Figure S1. Anti-tumor activity of

YIV906 500mgkg po bid x7 days plus different dose of antiPD1 70ug or 200ugmice ip once against Hepa 16 in vivo Tumor size at the beginning were about 270mm 3. Supplementary Figure 2.YFP is appropriately expressed in the Sox10-expressing cells and their derivatives in Sox10::iCreERtransgenics. (A-B) YFP immunostaining of E12.5 pression was detected in DRG, n Figure 6. Anti-redeposition Performance vs. Stain Type (Mini-Washer)Figure 7. Anti-redeposition Performance vs. Water HardnessChlorine StabilityThe excellent oxidation stability of ACUSOL 505N deterge Supplementary Figure . 2A:. . T-wave morphology changes upon stand-up test in LQTS . patients according to genotype. . Leads. – II, III, aVF. . Supplementary Figure . 2B:. . T-wave morphology changes upon stand-up test in LQTS patients according to . Figure . 1.. . A. . Gating . strategy for monocyte . identification. . PBMCs were processed as described in Figure 1 and acquired on a . FACSCalibur. flow cytometer. . Left panel:. Initial . cell gate was delineated on . washed repeatedly in PBS and PBS containing 0.3% Triton X-100 (PBS/Triton), and then incubated in blocking buffer (5% normal goat serum, 0.2% cold white fish skin gelatin, PBS/Triton) for 1 hour. Sections were then incubated with mouse anti-tyrosine hydroxylase (1:1000; Millipore; Billerica, MA) for 48 hours at 4°C. They were subsequently washed five times in PBS/Triton before being incubated with . . . Somatic mutation spectrum. # Substitutions. # Substitutions per Mb. b. c. a. # Substitutions per Mb. Repeats. Pseudogenes. Whole genome. Splice sites. Non-coding RNA. Intron. Promoter. 5’ UTR. 3’ UTR. : Crystal structure B - factor distribution and electron density quality. a) Rendering of YaxA, PaxB and YaxB crystal structures by B - factor values. For PaxB, all four NCS - related copies are show hCMEC. /D3 cells. The TEM shows one astrocyte in direct contact with the endothelium. . Scale bar = 2. μ. m.. Endothelium. Astrocyte. Collagen gel. Supplementary figure 2. Transmission electron micrograph of . PCR amplification of . Sub1 . QTL controlling submergence tolerance using Sub1-A203 marker in . BC1F1 progenies . L. Positive parent. Negative parent. MSS-8. MSS-9. MSS-28. MSS-31. MSS-37. MSS-52. MSS-76. E. F. A. C. D. APCMin. /+. APCMin. /+/C3aR-/-. APCMin. /+/C3aR-/-. APCMin. /+. APCMin. /+. APCMin. /+/C3aR-/-. APCMin. /+. APCMin. /+/C3aR-/-. APCMin. /+/C3aR-/-. APCMin. /+. APCMin. /+. APCMin. /+/C3aR-/-. mJ. /cm. 2. was range of UV irradiation.. Supplementary data . Figure S2. Total phenolic and flavonoid contents of DW extract of . Nypa. . fruticans. . (NFD) and 100% . EtOH. extract of . Nypa. . Consort flow chart summarizing the number of patients screened, enrolled, treated and followed on the study. *one patient was re-assessed for eligibility at recurrence and re-enrolled on the study. Created with BioRender.com.. PsaM. proteins. Blue mark indicate conservation of amino acids below 90%.. Supplementary Figure 2. . (A) Phylogenetic tree of . PsaM. genes showing five clusters (mentioned as 1, 2, 3, 4, and 5). (B).